Pharmacology & Pharmacy
Vol.4 No.9(2013), Paper ID 40577, 16
pages
DOI:10.4236/pp.2013.49093
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E3024, a Novel and Selective Dipeptidyl Peptidase-IV Inhibitor, in Healthy Japanese Male Subjects: Rash Development in Men and Its Possible Mechanism
Yutaka Takeuchi, Masayuki Namiki, Yasumi Kitahara, Setsuo Hasegawa, Akihiro Ohnishi, Nobuyuki Yasuda, Takashi Inoue, Richard Clark, Kazuto Yamazaki
Clinical Development, Japan/Asia Clinical Research PCU, Eisai Co., Ltd., Tokyo, Japan
Clinical Pharmacology, Clinical Science, SOCS CFU, Eisai Co., Ltd., Tokyo, Japan;
Clinical Development, Japan/Asia Clinical Research PCU, Eisai Co., Ltd., Tokyo, Japan;
Sekino Clinical Pharmacology Clinic, Tokyo, Japan; Present Address: Pharmaspur, Inc., Tokyo, Japan;
Department of Laboratory Medicine, Daisan Hospital, Jikei University School of Medicine, Tokyo, Japan;
Tsukuba Research Laboratories, Eisai Co., Ltd., Tsukuba, Japan.
Tsukuba Research Laboratories, Eisai Co., Ltd., Tsukuba, Japan.
Tsukuba Research Laboratories, Eisai Co., Ltd., Tsukuba, Japan.
Tsukuba Research Laboratories, Eisai Co., Ltd., Tsukuba, Japan.
Copyright © 2013 Yutaka Takeuchi, Masayuki Namiki, Yasumi Kitahara, Setsuo Hasegawa, Akihiro Ohnishi, Nobuyuki Yasuda, Takashi Inoue, Richard Clark, Kazuto Yamazaki et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Y. Takeuchi, M. Namiki, Y. Kitahara, S. Hasegawa, A. Ohnishi, N. Yasuda, T. Inoue, R. Clark and K. Yamazaki, "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of E3024, a Novel and Selective Dipeptidyl Peptidase-IV Inhibitor, in Healthy Japanese Male Subjects: Rash Development in Men and Its Possible Mechanism,"
Pharmacology & Pharmacy, Vol. 4 No. 9, 2013, pp. 663-678. doi:
10.4236/pp.2013.49093.